Diabetes Metab J.  2024 Jul;48(4):818-819. 10.4093/dmj.2024.0154.

Clinical Characteristics of Diabetes in People with Mitochondrial DNA 3243A>G Mutation in Korea (Diabetes Metab J 2024;48:482-6)

• Rho EH
• Kwak SH

• KMID: 2558049
• DOI: http://doi.org/10.4093/dmj.2024.0154

Reference

1. Rho EH, Baek SI, Lee H, Seong MW, Chae JH, Park KS, et al. Clinical characteristics of diabetes in people with mitochondrial DNA 3243A>G mutation in Korea. Diabetes Metab J. 2024; 48:482–6.

2. Finsterer J. Rare phenotypic manifestations of MELAS. Yonsei Med J. 2020; 61:904–6.

3. Wu G, Shen Y, Zhu F, Tao W, Zhou Y, Ke S, et al. Comprehensive diagnostic criteria for MELAS syndrome: a case study involving an elderly patient with MT-TWm.5541C>T mutation. Neurologist. 2023; 28:190–4.

4. Goel H, Szczepanczyk K, Mirza FS. Late-onset MELAS with MIDD: an uncommon age of presentation. AACE Clin Case Rep. 2018; 4:228–31.

5. de Laat P, Koene S, van den Heuvel LP, Rodenburg RJ, Janssen MC, Smeitink JA. Clinical features and heteroplasmy in blood, urine and saliva in 34 Dutch families carrying the m.3243A > G mutation. J Inherit Metab Dis. 2012; 35:1059–69.

6. Laloi-Michelin M, Meas T, Ambonville C, Bellanne-Chantelot C, Beaufils S, Massin P, et al. The clinical variability of maternally inherited diabetes and deafness is associated with the degree of heteroplasmy in blood leukocytes. J Clin Endocrinol Metab. 2009; 94:3025–30.